Public signalCompany raiseAuto-indexed · Unverified
Trevarx Biomedical, Inc. raised $350K
Trevarx Biomedical, Inc.· PHILADELPHIA, US· Biotechnology· Filed Aug 4, 2025
Trevarx Biomedical, Inc. reported raising capital. Based in PHILADELPHIA, PENNSYLVANIA, US. First sale reported 2025-07-25. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.
Raised
$350,000
Confidence90%
Raised
$350,000
Investors
6
Jurisdiction
DELAWARE
On the record
- Location
- PHILADELPHIA, US
- Sector
- Biotechnology
- Record type
- Company raise
- Stage
- Reported raised
- Amount raised
- $350,000
- Target amount
- $750,000
- Filing date
- Aug 4, 2025
- Issuer type
- operating company
Gaps in the record
- Valuation and deal terms are not on the public record
- No company website on record
- Investors are not disclosed
- Not yet claimed or verified by the company
Filing details
- Jurisdiction of incorporation
- DELAWARE
- Industry group
- Biotechnology
- Number of investors
- 6
- Includes non-accredited investors
- No
- Revenue range
- Decline to Disclose
- Total offering amount
- $750,000
- Amendment
- No
People named on this filing
Officers, directors, managers and entities listed in the public filing.
Sources & provenance
“Operating company sold 350,000 USD under Reg D.”
View original filing (SEC EDGAR Form D)
Automatically indexed from SEC EDGAR Form D · filing dated Aug 4, 2025. Details beyond the filing have not been verified.
Tags
USCompanyBiotechnology$100K – $1MCompany Raise
Are you associated with Trevarx Biomedical, Inc.?
This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.
Claim this record